Neurocrine Biosciences, Inc. Common Stock (NBIX)
Across 21 earnings reports since Aug 03, 2021, Neurocrine Biosciences, Inc. Common Stock (NBIX) has a clear post-earnings pattern. It moves ±6.74% on average after reporting and finishes higher 47.6% of the time. Its largest post-earnings gain was +8.88% (May 05, 2026) and its largest decline was -18.46% (Feb 06, 2025). The next earnings report is predicted for 2026-10-28 (estimated).
Earnings reactions
How NBIX moved on each past earnings report.
Earnings Impact
Total Earnings
21
Avg Abs. Movement
±6.74%
Positive %
47.6%
Negative %
52.4%
Historical Earnings Statistics
| Date | Timing | Earnings move | SEC Filing |
|---|---|---|---|
| Jul 30, 2026 | ☽ POST | -10.25% | open_in_new |
| May 05, 2026 | ☽ POST | +8.88% | open_in_new |
| Feb 11, 2026 | ☽ POST | -10.48% | open_in_new |
| Oct 28, 2025 | ☽ POST | -6.36% | open_in_new |
Earnings Count
21
Total earnings in dataset
Avg Abs. Movement
±6.74%
Avg % price change on earnings
Institutional ownership
Holdings as of Jun 30, 2026 · SEC 13-F
SEC Filing Types
Recent SEC Filings
10 most recent| Form | Date Filed | View on EDGAR |
|---|---|---|
| 4 | 20260903 | open_in_new SEC.gov |
| 4 | 20260805 | open_in_new SEC.gov |
| 10-Q | 20260731 | open_in_new SEC.gov |
| 8-K/A | 20260731 | open_in_new SEC.gov |
| S-8 | 20260731 | open_in_new SEC.gov |
| 4 | 20260730 | open_in_new SEC.gov |
| 8-K | 20260730 | open_in_new SEC.gov |
| SCHEDULE 13G/A | 20260727 | open_in_new SEC.gov |
| 4 | 20260713 | open_in_new SEC.gov |
| 4 | 20260713 | open_in_new SEC.gov |
Frequently asked about NBIX earnings
When does Neurocrine Biosciences, Inc. Common Stock report earnings next? expand_more
Neurocrine Biosciences, Inc. Common Stock (NBIX)'s next earnings date is estimated for 2026-10-28. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.
How much does NBIX stock move after earnings? expand_more
Over 21 reports, NBIX has moved an average of ±6.74% the session after earnings, closing higher 47.6% of the time.
What was NBIX's biggest post-earnings move? expand_more
NBIX's largest post-earnings gain on record was +8.88% on May 05, 2026, and its largest decline was -18.46% on Feb 06, 2025.
Where can I find Neurocrine Biosciences, Inc. Common Stock's SEC filings? expand_more
All of Neurocrine Biosciences, Inc. Common Stock's SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.
Sector peers
- Aardvark Therapeutics, Inc. (AARD) earnings history chevron_right
- AbCellera Biologics Inc. Common Shares (ABCL) earnings history chevron_right
- ABEONA THERAPEUTICS INC. (ABEO) earnings history chevron_right
- Acumen Pharmaceuticals, Inc. Common Stock (ABOS) earnings history chevron_right
- Arbutus Biopharma Corp (ABUS) earnings history chevron_right
- ABVC BioPharma, Inc. Common Stock (ABVC) earnings history chevron_right
- ACADIA PHARMACEUTICALS INC (ACAD) earnings history chevron_right
- Adicet Bio, Inc. Common Stock (ACET) earnings history chevron_right
- Acadia Healthcare Company, Inc. Common Stock (ACHC) earnings history chevron_right
- Achieve Life Sciences, Inc. Common Shares (ACHV) earnings history chevron_right